The aim of this study was to investigate whether the albumin value and the ratios of biochemical markers such as the hemoglobin, albumin, lymphocyte and platelet score (HALP), and the lymphocyte–C-reactive protein ratio (LCR) can predict survival and recurrence of the disease in patients with pancreatic adenocarcinoma. This evidence concerns the gene CRP and pancreatic adenocarcinoma.